175 related articles for article (PubMed ID: 7812773)
41. Autoradiographic distribution of binding sites for the non-NMDA receptor antagonist [3H]CNQX in human motor cortex, brainstem and spinal cord.
Chinnery RM; Shaw PJ; Ince PG; Johnson M
Brain Res; 1993 Dec; 630(1-2):75-81. PubMed ID: 7906998
[TBL] [Abstract][Full Text] [Related]
42. Expression of secreted phosphoprotein 1 (osteopontin) in human sensorimotor cortex and spinal cord: Changes in patients with amyotrophic lateral sclerosis.
Yamamoto T; Murayama S; Takao M; Isa T; Higo N
Brain Res; 2017 Jan; 1655():168-175. PubMed ID: 27823929
[TBL] [Abstract][Full Text] [Related]
43. Kinesin and cytoplasmic dynein in spinal spheroids with motor neuron disease.
Toyoshima I; Sugawara M; Kato K; Wada C; Hirota K; Hasegawa K; Kowa H; Sheetz MP; Masamune O
J Neurol Sci; 1998 Jul; 159(1):38-44. PubMed ID: 9700701
[TBL] [Abstract][Full Text] [Related]
44. TDP-43 expression in mouse models of amyotrophic lateral sclerosis and spinal muscular atrophy.
Turner BJ; Bäumer D; Parkinson NJ; Scaber J; Ansorge O; Talbot K
BMC Neurosci; 2008 Oct; 9():104. PubMed ID: 18957104
[TBL] [Abstract][Full Text] [Related]
45. Neurochemical changes in the spinal cord in degenerative motor neuron diseases.
Nagata Y; Fujita K; Yamauchi M; Kato T; Ando M; Honda M
Mol Chem Neuropathol; 1998 Apr; 33(3):237-47. PubMed ID: 9642676
[TBL] [Abstract][Full Text] [Related]
46. Ultrastructural study of the synapses of central chromatolytic anterior horn cells in motor neuron disease.
Sasaki S; Iwata M
J Neuropathol Exp Neurol; 1996 Aug; 55(8):932-9. PubMed ID: 8759783
[TBL] [Abstract][Full Text] [Related]
47. FAC1 expression and localization in motor neurons of developing, adult, and amyotrophic lateral sclerosis spinal cord.
Mu X; Springer JE; Bowser R
Exp Neurol; 1997 Jul; 146(1):17-24. PubMed ID: 9225734
[TBL] [Abstract][Full Text] [Related]
48. Onuf's nucleus is frequently involved in motor neuron disease/amyotrophic lateral sclerosis.
Bergmann M; Völpel M; Kuchelmeister K
J Neurol Sci; 1995 Apr; 129(2):141-6. PubMed ID: 7608728
[TBL] [Abstract][Full Text] [Related]
49. Increased [35S]glutathione binding sites in spinal cords from patients with sporadic amyotrophic lateral sclerosis.
Lanius RA; Krieger C; Wagey R; Shaw CA
Neurosci Lett; 1993 Nov; 163(1):89-92. PubMed ID: 8295742
[TBL] [Abstract][Full Text] [Related]
50. No re-expression of high-affinity nerve growth factor binding sites in spinal motor neurons in amyotrophic lateral sclerosis.
Aquilonius SM; Askmark H; Ebendal T; Gillberg PG
Eur Neurol; 1992; 32(4):216-8. PubMed ID: 1324179
[TBL] [Abstract][Full Text] [Related]
51. Synaptophysin in spinal anterior horn in aging and ALS: an immunohistological study.
Cruz-Sánchez FF; Moral A; Rossi ML; Quintó L; Castejón C; Tolosa E; de Belleroche J
J Neural Transm (Vienna); 1996; 103(11):1317-29. PubMed ID: 9013418
[TBL] [Abstract][Full Text] [Related]
52. Primary lateral sclerosis: upper-motor-predominant amyotrophic lateral sclerosis with frontotemporal lobar degeneration--immunohistochemical and biochemical analyses of TDP-43.
Kosaka T; Fu YJ; Shiga A; Ishidaira H; Tan CF; Tani T; Koike R; Onodera O; Nishizawa M; Kakita A; Takahashi H
Neuropathology; 2012 Aug; 32(4):373-84. PubMed ID: 22098653
[TBL] [Abstract][Full Text] [Related]
53. The Overexpression of TDP-43 Protein in the Neuron and Oligodendrocyte Cells Causes the Progressive Motor Neuron Degeneration in the SOD1 G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.
Lu Y; Tang C; Zhu L; Li J; Liang H; Zhang J; Xu R
Int J Biol Sci; 2016; 12(9):1140-9. PubMed ID: 27570488
[TBL] [Abstract][Full Text] [Related]
54. Role of complement in motor neuron disease: animal models and therapeutic potential of complement inhibitors.
Woodruff TM; Costantini KJ; Taylor SM; Noakes PG
Adv Exp Med Biol; 2008; 632():143-58. PubMed ID: 19025120
[TBL] [Abstract][Full Text] [Related]
55. Involvement of spinal sensory pathway in ALS and specificity of cord atrophy to lower motor neuron degeneration.
Cohen-Adad J; El Mendili MM; Morizot-Koutlidis R; Lehéricy S; Meininger V; Blancho S; Rossignol S; Benali H; Pradat PF
Amyotroph Lateral Scler Frontotemporal Degener; 2013 Jan; 14(1):30-8. PubMed ID: 22881412
[TBL] [Abstract][Full Text] [Related]
56. Age-Related Uptake of Heavy Metals in Human Spinal Interneurons.
Pamphlett R; Kum Jew S
PLoS One; 2016; 11(9):e0162260. PubMed ID: 27611334
[TBL] [Abstract][Full Text] [Related]
57. Regional distribution of cholinergic neurons in human spinal cord transections in the patients with and without motor neuron disease.
Nagata Y; Okuya M; Watanabe R; Honda M
Brain Res; 1982 Jul; 244(2):223-9. PubMed ID: 6288185
[TBL] [Abstract][Full Text] [Related]
58. Synaptosomal glutamate uptake declines progressively in the spinal cord of a mutant mouse with motor neuron disease.
Battaglioli G; Martin DL; Plummer J; Messer A
J Neurochem; 1993 Apr; 60(4):1567-9. PubMed ID: 8095977
[TBL] [Abstract][Full Text] [Related]
59. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
[TBL] [Abstract][Full Text] [Related]
60. Estimation of the prevalence and incidence of motor neuron diseases in two Spanish regions: Catalonia and Valencia.
Barceló MA; Povedano M; Vázquez-Costa JF; Franquet Á; Solans M; Saez M
Sci Rep; 2021 Mar; 11(1):6207. PubMed ID: 33737526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
